北交所策略专题报告：开源证券AI+医疗渗透提升项自主智能体升级，掘金北交所AI诊疗标的

Group 1 - The report highlights the dual drivers of policy empowerment and technological iteration in the AI+medical sector, indicating a comprehensive penetration of AI technologies across various medical industry segments [3][11][12] - AI in healthcare is defined as an intelligent application system that utilizes machine learning, natural language processing, and computer vision to analyze complex medical data, assisting clinical decision-making and optimizing treatment processes [3][11] - By 2024, the global market for AI healthcare solutions is projected to reach 40 billion yuan, with expectations to grow to 44.9 billion yuan by 2025, while the Chinese market is expected to reach 16.4 billion yuan in 2024 and 18.2 billion yuan in 2025 [3][21][22] Group 2 - The report notes that the North Exchange's pharmaceutical and biological sector saw a weekly increase of 0.34%, with traditional Chinese medicine experiencing a rise of 1.15% [4][28][29] - Among the 170 companies queued for listing on the North Exchange, 14 are related to the pharmaceutical and biological sector, with an average revenue of 438 million yuan and an average net profit of 105 million yuan for 2024 [4][42] - Companies such as JinHao Medical, WuXi Crystal Sea, and DeYuan Pharmaceutical reported significant year-on-year net profit growth exceeding 10% in their 2025 performance reports [4][43] Group 3 - The report identifies key companies in the AI+medical sector listed on the North Exchange, including DanNa Biological, BeiYiKang, JinHao Medical, and LuDe Medical, among others [3][26] - Specific highlights of these companies include DanNa Biological's focus on pathogen diagnosis, BeiYiKang's development of AI-assisted medical devices, and JinHao Medical's achievements in the hearing aid industry [26][27] - The report emphasizes the importance of AI technologies in enhancing diagnostic efficiency, reducing costs, and improving patient care across various applications such as imaging diagnostics, drug development, and clinical decision support [17][18][22]